275 related articles for article (PubMed ID: 28500075)
1. Overexpression of Human CD55 and CD59 or Treatment with Human CD55 Protects against Renal Ischemia-Reperfusion Injury in Mice.
Bongoni AK; Lu B; Salvaris EJ; Roberts V; Fang D; McRae JL; Fisicaro N; Dwyer KM; Cowan PJ
J Immunol; 2017 Jun; 198(12):4837-4845. PubMed ID: 28500075
[TBL] [Abstract][Full Text] [Related]
2. Critical protection from renal ischemia reperfusion injury by CD55 and CD59.
Yamada K; Miwa T; Liu J; Nangaku M; Song WC
J Immunol; 2004 Mar; 172(6):3869-75. PubMed ID: 15004194
[TBL] [Abstract][Full Text] [Related]
3. Blocking properdin, the alternative pathway, and anaphylatoxin receptors ameliorates renal ischemia-reperfusion injury in decay-accelerating factor and CD59 double-knockout mice.
Miwa T; Sato S; Gullipalli D; Nangaku M; Song WC
J Immunol; 2013 Apr; 190(7):3552-9. PubMed ID: 23427256
[TBL] [Abstract][Full Text] [Related]
4. High-level co-expression of complement regulators on vascular endothelium in transgenic mice: CD55 and CD59 provide greater protection from human complement-mediated injury than CD59 alone.
Cowan PJ; Shinkel TA; Aminian A; Romanella M; Wigley PL; Lonie AJ; Nottle MB; Pearse MJ; d'Apice AJ
Xenotransplantation; 1998 Aug; 5(3):184-90. PubMed ID: 9741456
[TBL] [Abstract][Full Text] [Related]
5. Generation of GTKO Diannan Miniature Pig Expressing Human Complementary Regulator Proteins hCD55 and hCD59 via T2A Peptide-Based Bicistronic Vectors and SCNT.
Liu F; Liu J; Yuan Z; Qing Y; Li H; Xu K; Zhu W; Zhao H; Jia B; Pan W; Guo J; Zhang X; Cheng W; Wang W; Zhao HY; Wei HJ
Mol Biotechnol; 2018 Aug; 60(8):550-562. PubMed ID: 29916131
[TBL] [Abstract][Full Text] [Related]
6. Blockade of the G-CSF Receptor Is Protective in a Mouse Model of Renal Ischemia-Reperfusion Injury.
McRae JL; Vikstrom IB; Bongoni AK; Salvaris EJ; Fisicaro N; Ng M; Alhamdoosh M; Baz Morelli A; Cowan PJ; Pearse MJ
J Immunol; 2020 Sep; 205(5):1433-1440. PubMed ID: 32839213
[TBL] [Abstract][Full Text] [Related]
7. Characterization of human CD55 and CD59 transgenic pigs and kidney xenotransplantation in the pig-to-baboon combination.
Ménoret S; Plat M; Blancho G; Martinat-Botté F; Bernard P; Karam G; Tesson L; Renaudin K; Guillouet P; Weill B; Chéreau C; Houdebine LM; Soulillou JP; Terqui M; Anegon I
Transplantation; 2004 May; 77(9):1468-71. PubMed ID: 15167611
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation.
De Vries B; Matthijsen RA; Wolfs TG; Van Bijnen AA; Heeringa P; Buurman WA
Transplantation; 2003 Feb; 75(3):375-82. PubMed ID: 12589162
[TBL] [Abstract][Full Text] [Related]
9. Complement regulatory molecules on human myelin and glial cells: differential expression affects the deposition of activated complement proteins.
Koski CL; Estep AE; Sawant-Mane S; Shin ML; Highbarger L; Hansch GM
J Neurochem; 1996 Jan; 66(1):303-12. PubMed ID: 8522968
[TBL] [Abstract][Full Text] [Related]
10. Production of multiple transgenic Yucatan miniature pigs expressing human complement regulatory factors, human CD55, CD59, and H-transferase genes.
Jeong YH; Park CH; Jang GH; Jeong YI; Hwang IS; Jeong YW; Kim YK; Shin T; Kim NH; Hyun SH; Jeung EB; Hwang WS
PLoS One; 2013; 8(5):e63241. PubMed ID: 23704897
[TBL] [Abstract][Full Text] [Related]
11. The protective role of CD59 and pathogenic role of complement in hepatic ischemia and reperfusion injury.
Zhang J; Hu W; Xing W; You T; Xu J; Qin X; Peng Z
Am J Pathol; 2011 Dec; 179(6):2876-84. PubMed ID: 22019898
[TBL] [Abstract][Full Text] [Related]
12. DAF/CD55 and Protectin/CD59 modulate adaptive immunity and disease outcome in experimental autoimmune myasthenia gravis.
Soltys J; Halperin JA; Xuebin Q
J Neuroimmunol; 2012 Mar; 244(1-2):63-9. PubMed ID: 22325826
[TBL] [Abstract][Full Text] [Related]
13. Labile Heme Aggravates Renal Inflammation and Complement Activation After Ischemia Reperfusion Injury.
Wang L; Vijayan V; Jang MS; Thorenz A; Greite R; Rong S; Chen R; Shushakova N; Tudorache I; Derlin K; Pradhan P; Madyaningrana K; Madrahimov N; Bräsen JH; Lichtinghagen R; van Kooten C; Huber-Lang M; Haller H; Immenschuh S; Gueler F
Front Immunol; 2019; 10():2975. PubMed ID: 31921212
[No Abstract] [Full Text] [Related]
14. Respective roles of decay-accelerating factor and CD59 in circumventing glomerular injury in acute nephrotoxic serum nephritis.
Lin F; Salant DJ; Meyerson H; Emancipator S; Morgan BP; Medof ME
J Immunol; 2004 Feb; 172(4):2636-42. PubMed ID: 14764738
[TBL] [Abstract][Full Text] [Related]
15. Association of the 5'HS4 sequence of the chicken beta-globin locus control region with human EF1 alpha gene promoter induces ubiquitous and high expression of human CD55 and CD59 cDNAs in transgenic rabbits.
Taboit-Dameron F; Malassagne B; Viglietta C; Puissant C; Leroux-Coyau M; Chéreau C; Attal J; Weill B; Houdebine LM
Transgenic Res; 1999 Jun; 8(3):223-35. PubMed ID: 10478492
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of the complement activating capacity of 17-1A mAb to overcome the effect of membrane-bound complement regulatory proteins on colorectal carcinoma.
Gelderman KA; Kuppen PJ; Bruin W; Fleuren GJ; Gorter A
Eur J Immunol; 2002 Jan; 32(1):128-35. PubMed ID: 11754353
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of different combinations of human MCP, DAF, and CD59 on complement-dependent cytolysis in NIH 3T3 cells.
Yang X; Deng J; Jiang Z; Liao DJ; Jiang H
Exp Clin Transplant; 2012 Feb; 10(1):49-54. PubMed ID: 22309420
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting the complement system does not reduce injury in renal ischemia reperfusion.
Park P; Haas M; Cunningham PN; Alexander JJ; Bao L; Guthridge JM; Kraus DM; Holers VM; Quigg RJ
J Am Soc Nephrol; 2001 Jul; 12(7):1383-1390. PubMed ID: 11423567
[TBL] [Abstract][Full Text] [Related]
19. Cytokine-mediated up-regulation of CD55 and CD59 protects human hepatoma cells from complement attack.
Spiller OB; Criado-García O; Rodríguez De Córdoba S; Morgan BP
Clin Exp Immunol; 2000 Aug; 121(2):234-41. PubMed ID: 10931136
[TBL] [Abstract][Full Text] [Related]
20. Potentiating Tissue-Resident Type 2 Innate Lymphoid Cells by IL-33 to Prevent Renal Ischemia-Reperfusion Injury.
Cao Q; Wang Y; Niu Z; Wang C; Wang R; Zhang Z; Chen T; Wang XM; Li Q; Lee VWS; Huang Q; Tan J; Guo M; Wang YM; Zheng G; Yu D; Alexander SI; Wang H; Harris DCH
J Am Soc Nephrol; 2018 Mar; 29(3):961-976. PubMed ID: 29295873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
